1. Antiresorptive treatment-associated ONJ
   Evangelos Eleutherakis-Papaiakovou et al, 2017, European Journal of Cancer Care CrossRef
2. A systematic review assessing occurrence of medication-related osteonecrosis of the jaw following dental procedures
   Shimelly Monteiro de Castro Lara et al, 2022, Brazilian Journal of Oral Sciences CrossRef
3. Current Knowledge, Drug-Based Therapeutic Options and Future Directions in Managing Osteoporosis
   Ali Moshiri et al, 2017, Clinical Reviews in Bone and Mineral Metabolism CrossRef
4. Moderate osteoporosis itself is beneficial for bones
   Zhonghua Xiong et al, 2020, Medical Hypotheses CrossRef
5. Factors Influencing Severity of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study
   Zhiqiang Feng et al, 2021, Journal of Oral and Maxillofacial Surgery CrossRef
6. Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case–control study
   Alberto Bedogni et al, 2019, Journal of Cranio-Maxillofacial Surgery CrossRef
7. Systematic evaluation of the mechanisms of zoledronic acid based on network pharmacology
   Xue-Zhen Liang et al, 2019, Computational Biology and Chemistry CrossRef
8. Bisphosphonates as Supplement to Dental Treatment: A Network Meta-Analysis
   V.F. Zymperdikas et al, 2021, Journal of Dental Research CrossRef
9. Zoledronic acid induces micronuclei formation, mitochondrial-mediated apoptosis and cytostasis in kidney cells
   Soma Shiva Nageswara Rao Singireesu et al, 2018, Life Sciences CrossRef
10. Perimandibular abscess associated with bisphosphonate‐related osteonecrosis of the jaw
    Kazuki Ocho et al, 2017, Journal of General and Family Medicine CrossRef